骨钙素与认知功能障碍机制的研究进展

doi:10.3969/j.issn.1003-9198.2022.09.020

[1] ROUSSEAUD A, MORICEAU S, RAMOS-BROSSIER M, et al. Bone-brain crosstalk and potential associated diseases[J]. Horm Mol Biol Clin Investig, 2016, 28(2):69-83.
[2] ZHOU R, DENG J, ZHANG M, et al. Association between bone mineral density and the risk of Alzheimer's disease[J]. J Alzheimers Dis, 2011, 24(1):101-108.
[3] SOHRABI H R, BATES K A, WEINBORN M, et al. Bone mineral density, adiposity, and cognitive functions[J]. Front Aging Neurosci, 2015, 7:16.
[4] NOH H M, OH S, SONG H J, et al. Relationships between cognitive function and body composition among community-dwelling older adults: a cross-sectional study[J]. BMC Geriatr, 2017,17(1):259.
[5] PU Z, TANG X, FEI Y, et al. Bone metabolic biomarkers and bone mineral density in male patients with early-stage Alzheimer's disease[J]. Eur Geriatr Med, 2020,11(3):403-408.
[6] MOSER S C, VAN DER EERDEN B C J. Osteocalcin-a versatile bone-derived hormone[J]. Front Endocrinol:Lausanne, 2019,9:794.
[7] OURY F, KHRIMIAN L, DENNY C A, et al. Maternal and offspring pools of osteocalcin influence brain development and functions[J]. Cell, 2013,155(1):228-241.
[8] GU P Y, YU F, JIN S, et al. Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment[J]. Exp Ther Med, 2017,14(3):2603-2607.
[9] BRADBURN S, MCPHEE J S, BAGLEY L, et al. Association between osteocalcin and cognitive performance in healthy older adults[J]. Age Ageing, 2016,45(6):844-849.
[10] PUIG J, BLASCO G, DAUNIS-I-ESTADELLA J, et al. Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance[J]. Clin Endocrinol:Oxf, 2016,84(5):756-763.
[11] NAKAMURA M, IMAOKA M, TAKEDA M, Interaction of bone and brain: osteocalcin and cognition[J]. Int J Neurosci, 2021,131(11):1115-1123.
[12] SHAN C, GHOSH A, GUO X Z, et al. Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders[J]. Mol Brain, 2019,12(1):23.
[13] CHEN H, SHANG D, WEN Y, et al. Bone-derived modulators that regulate brain function: emerging therapeutic targets for neurological disorders[J]. Front Cell Dev Biol, 2021,9:683457.
[14] KHRIMIAN L, OBRI A, RAMOS-BROSSIER M, et al. Gpr158 mediates osteocalcin's regulation of cognition[J]. J Exp Med, 2017, 214(10):2859-2873.
[15] OBRI A, KHRIMIAN L, KARSENTY G, et al. Osteocalcin in the brain: from embryonic development to age-related decline in cognition[J]. Nat Rev Endocrinol, 2018,14(3):174-182.
[16] MIZOGUCHI Y, YAO H, IMAMURA Y, et al. Lower brain-derived neurotrophic factor levels are associated with age-related memory impairment in community-dwelling older adults: the Sefuri study[J]. Sci Rep, 2020,10(1):16442.
[17] RODRíGUEZ-BERDINI L, CAPUTTO B L. Lipid metabolism in neurons: a brief story of a novel c-Fos-dependent mechanism for the regulation of their synthesis[J]. Front Cell Neurosci, 2019, 13:198.
[18] PAVLOPOULOS E, JONES S, KOSMIDIS S, et al. Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48[J]. Sci Transl Med, 2013, 5(200):200ra115.
[19] KOSMIDIS S, POLYZOS A, HARVEY L, et al. RbAp48 protein is a critical component of GPR158/OCN signaling and ameliorates age-related memory loss[J]. Cell Rep, 2018, 25(4):959-973.e6.
[20] ÇETEREISI D, KRAMVIS I, GEBUIS T, et al. Gpr158 deficiency impacts hippocampal CA1 neuronal excitability, dendritic architecture, and affects spatial learning[J]. Front Cell Neurosci, 2019, 13:465.
[21] CONDOMITTI G, WIERDA K D, SCHROEDER A, et al. An input-specific orphan receptor GPR158-HSPG interaction organizes hippocampal mossy fiber-CA3 synapses[J]. Neuron, 2018, 100(1):201-215.e9.
[22] KOMORI T. Functions of osteocalcin in bone, pancreas, testis, and muscle[J]. Int J Mol Sci, 2020, 21(20):7513.
[23] DUCY P. Bone regulation of insulin secretion and glucose homeostasis[J]. Endocrinology, 2020, 161(10):bqaa149.
[24] LEE N K, SOWA H, HINOI E, et al. Endocrine regulation of energy metabolism by the skeleton[J]. Cell, 2007,130(3):456-469.
[25] MIZOKAMI A, YASUTAKE Y, GAO J, et al. Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice[J]. PLoS One, 2013,8(2):e57375.
[26] RIEDERER P, KORCZYN A D, Ali S S, et al. The diabetic brain and cognition[J]. J Neural Transm:Vienna, 2017,124(11):1431-1454.
[27] OTANI T, MIZOKAMI A, KAWAKUBO-YASUKOCHI T, et al. The roles of osteocalcin in lipid metabolism in adipose tissue and liver[J]. Adv Biol Regul, 2020, 78:100752.
[28] 包玉倩.骨钙素介导的骨骼-心血管“对话”[J]. 中华内分泌代谢杂志, 2019, 35(6):455-459.
[29] RIZZO M R, FASANO R, PAOLISSO G. Adiponectin and cognitive decline[J]. Int J Mol Sci, 2020,21(6):2010.
[30] LETRA L, RODRIGUES T, MATAFOME P, et al. Adiponectin and sporadic Alzheimer's disease: clinical and molecular links[J]. Front Neuroendocrinol, 2019,52:1-11.
[31] ROJAS M, CHÁVEZ-CASTILLO M, PIRELA D, et al. Metabolic syndrome: is it time to add the central nervous system?[J]. Nutrients, 2021, 13(7):2254.
[32] CHEN W H, JIN W, LYU P Y, et al. Carotid atherosclerosis and cognitive impairment in nonstroke patients[J]. Chin Med J: Engl, 2017,130(19):2375-2379.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Metrics

Recommended 10

[1]	. [J]. Practical Geriatrics, 2024, 38(9): 880-883.
[2]	. [J]. Practical Geriatrics, 2024, 38(9): 948-952.
[3]	. [J]. Practical Geriatrics, 2024, 38(8): 770-774.
[4]	. [J]. Practical Geriatrics, 2024, 38(8): 857-861.
[5]	LI Qingyang, WANG Chanjuan, WANG Zheng. Study on the correlation of cognitive function with swallowing function and nutritional status in the elderly patients with Alzheimer’s disease [J]. Practical Geriatrics, 2024, 38(6): 577-581.
[6]	LIU Tian, YANG Rongli, HAN Huiping. Value of serum levels of Aβ1-42 and Bcl-2 in predicting the pathogenesis of Alzheimer’s disease in elderly patients with cognitive impairment [J]. Practical Geriatrics, 2024, 38(6): 582-586.
[7]	SHI Wen, ZHU Ping, ZHOU Jie, YAN Ting, HUANG Yujie, YAN Yan. Effect of pancreatic kallidinogenase on mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(6): 587-591.
[8]	. [J]. Practical Geriatrics, 2024, 38(6): 634-638.
[9]	ZHENG Qian, TAO Yue, CHEN Yi-qiang, LIU Si-yuan, CHEN De-zhu, PENG Lu, GU Shou-yong, CAI Min-qi, BAI Bing. Clinical value of serum amyloid-beta 42 and phosphorylated Tau in elderly patients [J]. Practical Geriatrics, 2022, 36(12): 1229-1232.
[10]	DU Hong-di, BO Lin, YIN Li-sha, LUO Dan-dan, HUO Xiao-peng. Effect of simulated presence therapy on apathy in patients with mild and moderate dementia [J]. Practical Geriatrics, 2022, 36(10): 1071-1074.
[11]	. [J]. Practical Geriatrics, 2022, 36(9): 959-962.
[12]	LIU Hong, LI Yan-zhang, ZHANG Hui, XIONG Mei, ZHANG Yu-ping. Relationship between frailty and cognitive function of community-dwelling elderly: the mediating mechanism of resilience [J]. Practical Geriatrics, 2022, 36(8): 842-845.
[13]	. [J]. Practical Geriatrics, 2022, 36(7): 660-662.
[14]	WANG Bian-rong, ZHENG Hui-fen, XU Chang, ZHANG He-di, HUANG Dan-qing, TIAN Qi, CHEN Chun-miao. Associations of angiotensin Ⅱ level with cognitive function and medial temporal atrophy in elderly [J]. Practical Geriatrics, 2022, 36(7): 684-687.